Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
astrazeneca
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cancer
eli lilly
merck
startups
alzheimer's disease
cancer immunotherapy
clinical trials
cystic fibrosis
deals
What
drug
4
×
bio
roundup
prices
week
acquisitions
alzheimer’s
annual
approved
assessed
attention
away
biggest
biotech
bringing
build
buy
ceo
ceos
communities
companies
company’s
conference
daniel
dc
debut
digital
disease
dyne’s
epidemic
esmo
europe
executives
fatty
fda
frenzied
gathered
germany
gilead
groups
Language
unset
Current search:
astrazeneca
×
drug
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
